Cis-resveratrol blocks crystal-induced NLRP3 inflammasome activation via the TRPV4-Ca²⁺-phagocytosis-ROS axis
Phytomedicine · 2025
DOI: 10.1016/j.phymed.2025.157145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2025. Verfasst von Shuhui Lei und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan 430065, PR China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes, TRPV Cation Channels. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: South-Central University for Nationalities, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Inflammation is a vital biological defense mechanism, yet uncontrolled or prolonged inflammation can cause tissue damage. The NLRP3 inflammasome, a central component of innate immunity, drives inflammation by activating caspase-1 and promoting the release of cytokines like IL-1β. Monosodium urate (MSU) crystals are potent NLRP3 inflammasome activators implicated in diseases such as gout. While resveratrol, a natural polyphenol, exhibits anti-inflammatory properties, the specific mechanisms by which its cis-isomer (Cis-Resv) inhibits NLRP3 inflammasome activation remain poorly understood. PURPOSE: This study aims to investigate the inhibitory effect of Cis-Resv on MSU-induced NLRP3 inflammasome activation and elucidate the underlying molecular mechanisms. METHODS: Bone marrow-derived macrophages (BMDMs) from C57BL/6J mice were stimulated with MSU crystals. The effects of Cis-Resv on IL-1β secretion, caspase-1 activation, and ASC oligomerization were evaluated using ELISA, Western blot, and immunoprecipitation, respectively. Transcriptomic analysis was employed to identify potential signaling pathways involved. The in vivo efficacy of Cis-Resv was assessed in MSU-induced acute gouty arthritis and air-pouch models by measuring joint swelling, inflammatory cytokines levels, and histopathological changes. RESULTS: Cis-Resv significantly inhibited MSU-induced NLRP3 inflammasome activation in BMDMs, reducing caspase-1 activation, IL-1β secretion, andassociated pyroptosis. Furthermore, Cis-Resv impeded ASC oligomerization, a critical step in inflammasome assembly. Transcriptomic analysis and subsequent functional validation revealed that Cis-Resv exerts these effects primarily through the TRPV4-Ca²⁺-phagocytosis-ROS signaling axis. Specifically, Cis-Resv inhibited macrophage TRPV4 channel activity, leading to decreased Ca²⁺ influx, impaired MSU crystal phagocytosis, and attenuated reactive oxygen species (ROS) accumulation. This reduction in ROS modulated the ROS-TXNIP pathway, diminishing the interaction between TXNIP and NLRP3, thereby suppressing inflammasome activation. In vivo, Cis-Resv effectively alleviated MSU-induced joint swelling, lowered IL-1β and TNF-α levels, and ameliorated histopathological damage in both gouty arthritis and air-pouch models. CONCLUSION: Cis-Resv suppresses MSU-induced NLRP3 inflammasome activation by targeting the TRPV4-Ca²⁺-phagocytosis-ROS axis. This study identifies a novel mechanism and suggests Cis-Resv as a potential therapeutic agent for NLRP3-driven inflammatory conditions like gout.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan 430065, PR China.
- School of Pharmacy, Hubei Shizhen Laboratory, Hubei University of Chinese Medicine, Wuhan 430065, PR China. Electronic address: lzlz_84@163.com.
- School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan 430065, PR China. Electronic address: clyhappy05@163.com.
Förderung
- South-Central University for Nationalities
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Lei, S., Liu, K., Liu, C., An, R., Bao, Z., Zhang, H., Zou, M., Chen, J., Zhang, H., Wei, L., Lan, Z., & Chen, L. (2025). Cis-resveratrol blocks crystal-induced NLRP3 inflammasome activation via the TRPV4-Ca²⁺-phagocytosis-ROS axis. Phytomedicine. https://doi.org/10.1016/j.phymed.2025.157145
Vancouver
Lei S, Liu K, Liu C, An R, Bao Z, Zhang H, et al. Cis-resveratrol blocks crystal-induced NLRP3 inflammasome activation via the TRPV4-Ca²⁺-phagocytosis-ROS axis. Phytomedicine. 2025. doi:10.1016/j.phymed.2025.157145
BibTeX
@article{Lei2025,
author = {Lei, Shuhui and Liu, Kaiqun and Liu, Cong and An, Ran and Bao, Zilu and Zhang, Huan and Zou, Min and Chen, Jianqiu and Zhang, HuiHui and Wei, Liangkai and Lan, Zhou and Chen, Lvyi},
title = {Cis-resveratrol blocks crystal-induced NLRP3 inflammasome activation via the TRPV4-Ca²⁺-phagocytosis-ROS axis},
journal = {Phytomedicine},
year = {2025},
doi = {10.1016/j.phymed.2025.157145}
}
EUVIMED